Meta-analysis when only the median survival times are known: A comparison with individual patient data results

International Journal of Technology Assessment in Health Care

Volumn 21, Issue 1, 2005, Pages 119-125

  Michiels, Stefan ^a   Piedbois, Pascal ^b   Burdett, Sarah ^c   Syz, Nathalie ^a   Stewart, Lesley ^c   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

Median survival time; Meta analysis; Summary data; Survival analysis; Time to event outcomes

Indexed keywords

DATA ACQUISITION; STATISTICAL METHODS; TUMORS;

MEDIAN SURVIVAL TIMES; META-ANALYSIS (MA); MORTALITY RATES; SURVIVAL RATES;

PATIENT MONITORING;

ARTICLE; CALCULATION; CANCER; CANCER SURVIVAL; CLINICAL TRIAL; DATA ANALYSIS; EVALUATION; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; INDIVIDUAL PATIENT DATA; META ANALYSIS; OUTCOMES RESEARCH; PATIENT CODING; PUBLICATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW;

EID: 13644267742     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462305050154     Document Type: Article

References (31)

1. Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol. 1994;12:960-969.
2. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol. 1992;10:896-903.
3. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72:511-518.
4. Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys. 1998;41:579-5S3.
5. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission (Prophylactic Cranial Irradiation Overview Collaborative Group). N Engl J Med. 1999;341:476-484.
6. Buyse M, Ryan LM. Issues of efficiency in combining proportions of deaths from several clinical trials. Stat Med. 1987;6:565-576.
7. Chalmers I. The Cochrane Collaboration: Preparing, maintaining and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 1993;703:156-165.
8. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-1291.
9. Duchatcau L, Pignon JP, Bijnens L, et al. Individual patient-versus literature-based meta-analysis of survival data: Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Control Clin Trials. 2001;22:538-547.
10. Easterbrook PJ, Berlin JA. Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991:337:867-872.
11. Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011-1018.
12. Greenland S, Salvan A. Bias in the one-step method for pooling study results. Stat Med. 1990;9:247-252.
13. Meta-Analysis Group in Cancer. Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced coloreetal cancer. BMJ. 2001;84:611-620.
14. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 1996;88: 252-258.
15. Meta-Analysis Group in Cancer. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors. J Clin Oncol. 1998;163:537-541.
16. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-1194.
17. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995:311:899-909.
18. IS. Parmar MKB, Torn W, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
19. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618-1624.
20. Pignon JP, Hill C. Meta-analyses of randomised clinical trials in oncology. Lancet Oncol. 2001;2:475-482.
21. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-263.
22. Simes RJ. Confronting publication bias: A cohort design for meta-analysis. Stat Med. 1987;6:11-29.
23. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med. 1986:105:429-435.
24. Stablein DM, Koutrouvelis IA. A two-sample test sensitive to crossing hazards in uncensored and singly censored data. Biometrics. 1985:41:643-652.
25. Stewart LA, Parmar MKB. Bias in the analysis and reporting of randomized controlled trials. Int J Technol Assess Health Care. 1996;12:264-275.
26. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet. 1993;341:418-422.
27. Tierney JF, Clarke M, Stewart LA. Is there bias in the publication of individual patient data meta-analyses? Int J Technol Assess Health Care. 2000;16:657-667.
28. Tudur C, Williamson PR, Khan S, Best LY. The value of the aggregated data approach in meta-analysis with time-to-event outcomes. J R Statist Soc A. 2001;164:357-370.
29. Vale CL, Tierncy JF, Stewart LA. Effects of adjusting for censoring on meta-analyses of time-to-event outcomes. Int J Epidemiol. 2002;31:107-111.
30. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med. 1991;10:1665-1677.
31. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.